Quantitative RT-PCR detection of colorectal tumor cells in peripheral blood--a systematic review
- PMID: 18621394
- DOI: 10.1016/j.jss.2008.02.012
Quantitative RT-PCR detection of colorectal tumor cells in peripheral blood--a systematic review
Abstract
Background: Twenty percent to 40% of patients with node-negative colorectal cancer die of metastatic disease. Detection of cancer cell dissemination has been proposed as a tool to select patients at highest risk for recurrence. In this review, we summarize the evidence for detection with quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) assays of circulating tumor cells (CTCs) in peripheral blood of colorectal cancer patients.
Materials and methods: Pubmed and Embase were systematically searched for all English publications relevant to circulating cancer cells, peripheral blood, quantitative RT-PCR (q-RT-PCR), and colorectal cancer. Cross-references and the "related articles" function were used to broaden the search. Manuscripts reporting on the results of nonquantitative RT-PCR assays were excluded. The study methodology, CTCs detection rates in peripheral blood, and prognostic value were reviewed.
Results: Twelve manuscripts on qRT-PCR were retrieved. Stage dependence was found for detection of CTCs in four of 10 studies. From univariate analysis performed for disease-free survival and overall survival in 4 of 12 studies, there was evidence (P < 0.05) for an effect of the detection of CTCs with qRT-PCR. None of the included trials identified detection of CTCs in peripheral blood as an independent predictor of survival.
Conclusion: Quantification of CTCs in peripheral blood holds promise in predicting stage and outcome in colorectal cancer patients. At present, evidence from the literature is too scarce to integrate quantitative RT-PCR assays to detect CTCs into the management of colorectal cancer.
Similar articles
-
Comparison of three distinct methods for the detection of circulating tumor cells in colorectal cancer patients.Oncol Rep. 2011 Jun;25(6):1669-703. doi: 10.3892/or.2011.1231. Epub 2011 Mar 23. Oncol Rep. 2011. PMID: 21455578
-
Prognostic significance of circulating tumor cells (CTCs) in Egyptian non-metastatic colorectal cancer patients: A comparative study for four different techniques of detection (Flowcytometry, CellSearch, Quantitative Real-time PCR and Cytomorphology).Exp Mol Pathol. 2019 Feb;106:90-101. doi: 10.1016/j.yexmp.2018.12.006. Epub 2018 Dec 19. Exp Mol Pathol. 2019. PMID: 30578762
-
Detection of cytokeratin 20 mRNA in the peripheral blood of patients with colorectal cancer by immunomagnetic bead enrichment and real-time reverse transcriptase-polymeras chain reaction.J Gastroenterol Hepatol. 2005 Aug;20(8):1279-84. doi: 10.1111/j.1440-1746.2005.03894.x. J Gastroenterol Hepatol. 2005. PMID: 16048578
-
Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer.J Urol. 1997 Aug;158(2):326-37. J Urol. 1997. PMID: 9224297 Review.
-
Micrometastatic disease in breast cancer: clinical implications.Eur J Cancer. 2008 Dec;44(18):2726-36. doi: 10.1016/j.ejca.2008.09.033. Eur J Cancer. 2008. PMID: 19056036 Review.
Cited by
-
Evaluation of the adenocarcinoma-associated gene AGR2 and the intestinal stem cell marker LGR5 as biomarkers in colorectal cancer.Int J Mol Sci. 2012;13(4):4367-4387. doi: 10.3390/ijms13044367. Epub 2012 Apr 5. Int J Mol Sci. 2012. PMID: 22605983 Free PMC article.
-
Detection and Clinical Significance of Circulating Tumor Cells in Colorectal Cancer--20 Years of Progress.Mol Med. 2015 Oct 27;21 Suppl 1(Suppl 1):S25-31. doi: 10.2119/molmed.2015.00149. Mol Med. 2015. PMID: 26605644 Free PMC article. Review.
-
Expression of Survivin, CK7, ASH1, HMGB3, L587S, and CLCA2 in Peripheral Blood of Lung Cancer Patients by Real-Time Polymerase Chain Reaction.Cureus. 2024 Jul 12;16(7):e64386. doi: 10.7759/cureus.64386. eCollection 2024 Jul. Cureus. 2024. PMID: 39130876 Free PMC article.
-
Influence of surgical manipulation and surgical modality on the molecular detection of circulating tumor cells from colorectal cancer.J Korean Surg Soc. 2012 Jun;82(6):356-64. doi: 10.4174/jkss.2012.82.6.356. Epub 2012 May 29. J Korean Surg Soc. 2012. PMID: 22708097 Free PMC article.
-
Role of specific DNA mutations in the peripheral blood of colorectal cancer patients for the assessment of tumor stage and residual disease following tumor resection.Oncol Lett. 2016 Nov;12(5):3356-3362. doi: 10.3892/ol.2016.5078. Epub 2016 Sep 1. Oncol Lett. 2016. PMID: 27900004 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
